SCHEMBL807311

SCHEMBL807311

O=C1CCCN1c1ccc2c(c1)CN(Cc1ccccc1)CCO2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 5/20 0.53
SIGMAR1 Q99720 5/20 0.53
ADRA2A P08913 2/20 0.49
ADRA2B P18089 2/20 0.49
DRD4 P21917 1/20 0.49
HRH1 P35367 1/20 0.49
HTR2B P41595 1/20 0.49
ADRA2C P18825 1/20 0.44
CYP2D6 P10635 3/20 0.43
ALDH1A1 P00352 3/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 2/20 0.41
HIF1A Q16665 1/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PTGER2 P43116 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL807309 0.85 TMEM97 (0.46) TMEM97SIGMAR1ADRA2AADRA2BDRD4
SCHEMBL807305 0.78 SIGMAR1 (0.71) TMEM97SIGMAR1ADRA2AADRA2BDRD4
SCHEMBL12445273 0.77 LMNA (0.51) CYP2D6ALDH1A1KMT2ACYP3A4LMNA
SCHEMBL14023200 0.77 ALDH1A1 (0.53) CYP2D6ALDH1A1KMT2ACYP3A4HIF1A
SCHEMBL3276408 0.75 CYP2D6 (0.51) TMEM97SIGMAR1ADRA2AADRA2BDRD4
SCHEMBL6436620 0.74 CYP2D6 (0.51) TMEM97SIGMAR1ADRA2AADRA2BDRD4
SCHEMBL807310 0.72 CYP2D6 (0.48) TMEM97SIGMAR1ADRA2AADRA2BDRD4
SCHEMBL4788136 0.72 DRD2 (0.51) TMEM97SIGMAR1ADRA2AADRA2BDRD4
SCHEMBL807032 0.72 CYP2D6 (0.53) TMEM97SIGMAR1ADRA2AADRA2BDRD4
SCHEMBL11117922 0.71 LMNA (0.63) CYP2D6ALDH1A1KMT2ACYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012037105-A1 METHODS OF TREATING, AMELIORATING OR PREVENTING STRESS-INDUCED NEURONAL DISORDERS AND DISEASES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2012-03-22 WO disclosed
WO-2012019071-A1 METHODS OF PREVENTING AND TREATING SARCOPENIA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2012-02-09 WO disclosed
WO-2012019076-A1 COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CARDIAC ISCHEMIA/REPERFUSION INJURY THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2012-02-09 WO disclosed
WO-2008144483-A2 AGENTS FOR TREATING DISORDERS INVOLVING MODULATION OF RYANODINE RECEPTORS ARMGO PHARMA, INC. (US) 2008-11-27 WO disclosed